GlaxoSmithKline Pakistan Ltd GLAXO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 23.64
- Price/Sales
- 1.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
GlaxoSmithKline Pakistan Ltd is engaged in research, development, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from Pharmaceuticals segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,708
- Website
- https://www.pk.gsk.com
Comparables
Valuation
|
Metric
|
GLAXO
|
HINOON
|
688189
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.64 | 12.72 | — |
Price/Book Value | 2.65 | 3.63 | 1.28 |
Price/Sales | 1.12 | 1.67 | 3.96 |
Price/Cash Flow | 13.51 | 10.83 | 13.84 |
Price/Earnings
GLAXO
HINOON
688189
Financial Strength
|
Metric
|
GLAXO
|
HINOON
|
688189
|
|---|---|---|---|
Quick Ratio | 0.81 | 1.66 | 4.18 |
Current Ratio | 1.66 | 3.20 | 4.40 |
Interest Coverage | — | 17.49 | −2.93 |
Quick Ratio
GLAXO
HINOON
688189
Profitability
|
Metric
|
GLAXO
|
HINOON
|
688189
|
|---|---|---|---|
Return on Assets (Normalized) | 6.63% | 20.60% | −1.65% |
Return on Equity (Normalized) | 12.02% | 30.16% | −2.15% |
Return on Invested Capital (Normalized) | 10.78% | 28.03% | −1.82% |
Return on Assets
GLAXO
HINOON
688189
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bltzbmxfs | Qnpq | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Mbwhhfdcr | Cvmsqj | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Wnpxltrk | Lkwc | $48.1 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Sfpgrcdk | Rqqx | $20.0 Bil | |||
| Viatris Inc
VTRS
| Pqmkxcpt | Qvpx | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Dwtxdxsw | Tckkn | $13.4 Bil | |||
| Catalent Inc
CTLT
| Hwphxly | Pnnncmq | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tjydydt | Pvxtxr | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Qvmybbvt | Bgvxx | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Pwwlkfbvh | Twllm | $2.5 Bil |
United States